| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | MaxCyte, Inc. - Total Voting Rights | - | RNS | ||
| 29.05. | MaxCyte, Inc: MaxCyte to Participate in William Blair 44th Annual Growth Stock Conference | 1 | GlobeNewswire (USA) | ||
| 29.05. | MaxCyte, Inc. - Participation in Upcoming Investor Conference | - | RNS | ||
| 22.05. | MaxCyte, Inc: MaxCyte Signs Strategic Platform License Agreement with Legend Biotech to Accelerate Cell Therapy Discovery and Development | 80 | GlobeNewswire (Europe) | ROCKVILLE, Md., May 22, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery... ► Artikel lesen | |
| 22.05. | MaxCyte, Inc. - Signing of Strategic Platform License | - | RNS | ||
| 14.05. | MaxCyte, Inc. - Holding(s) in Company | - | RNS | ||
| 08.05. | MaxCyte, Inc. - Filing of Form 10-Q | - | RNS | ||
| 08.05. | MaxCyte, Inc. - First Quarter Results | - | RNS | ||
| 07.05. | MAXCYTE, INC. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 07.05. | MAXCYTE, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 07.05. | MaxCyte, Inc: MaxCyte Reports First Quarter 2024 Financial Results and Updates 2024 Guidance | 32 | GlobeNewswire (Europe) | ROCKVILLE, Md., May 07, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery... ► Artikel lesen | |
| 07.05. | MaxCyte, Inc.: MaxCyte Reports First Quarter 2024 Financial Results and Updates 2024 Guidance | 1 | GlobeNewswire (USA) | ||
| 04.05. | MaxCyte Inc expected to post a loss of 13 cents a share - Earnings Preview | 1 | Reuters | ||
| 03.05. | MaxCyte, Inc. - Notice of AGM | - | RNS | ||
| 01.05. | MaxCyte, Inc. - Total Voting Rights | 1 | RNS | ||
| 10.04. | MaxCyte, Inc: MaxCyte to Report First Quarter 2024 Financial Results on May 7, 2024 | 1 | GlobeNewswire (USA) | ||
| 10.04. | MaxCyte, Inc. - Notice of Results | - | RNS | ||
| 02.04. | MaxCyte, Inc: MaxCyte Signs Strategic Platform License with Be Biopharma to Support the Development of Engineered B Cell Medicines (BCMs) | 1 | GlobeNewswire (USA) | ||
| 02.04. | MaxCyte, Inc. - Signing of Strategic Platform License | - | RNS | ||
| 02.04. | MaxCyte, Inc. - Exercise of options and PDMR dealing | - | RNS |
Seite:
1 2 3 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| TUI | 5.645 |
| GAMESTOP | 3.741 |
| NVIDIA | 3.575 |
| NEL | 3.571 |
| EVOTEC | 3.327 |
| BAYER | 2.551 |
| PLUG POWER | 2.032 |
| BYD | 1.910 |
| VOLKSWAGEN | 1.388 |
| DEUTSCHE LUFTHANSA | 1.281 |
| RHEINMETALL | 1.229 |
| DEUTSCHE TELEKOM | 1.149 |
| BIONTECH | 1.146 |
| SUPER MICRO COMPUTER | 1.131 |
| ALLIANZ | 1.097 |
| AIXTRON SE | 950 |
| DEUTSCHE BANK | 891 |
| SIEMENS ENERGY | 879 |
| COMMERZBANK | 843 |
| RWE | 838 |
| BASF | 821 |
| THYSSENKRUPP | 779 |
| TESLA | 752 |
| MERCEDES-BENZ | 716 |
| BARRICK GOLD | 673 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
